Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Rina Bandopadhyay
Based on 23 articles published since 2008
||||
Expertise Level
The expertise of Rina Bandopadhyay ranks in the
  • Top 1%
  • ... of 70,275 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 23 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Bandopadhyay, R   ·   Bandopadhyay, Rina
Work Locations
Details
Most likely:    University College London      
2017
  • Department of Molecular Neuroscience, Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, 1, Wakefield Street, London, WC1N 1PJ, UK. · Department of Molecular Neuroscience, Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, 1, Wakefield Street, London, WC1N 1PJ, UK. · Pubmed 28674978
  • Department of Biochemistry, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel. · Reta Lila Weston Institute of Neurological Studies, University College London Institute of Neurology, London WC1N 1PJ, United Kingdom. · Department of Biochemistry, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel; · Pubmed 29180403
  • School of Medical Sciences, University of New South Wales, Kensington, Australia. · Neuroscience Research Australia, Randwick, Australia. · Queen Square Brain Bank, UCL Institute of Neurology, University College London, London, UK. · Parkinson's Institute and Clinical Center, Sunnyvale, California, USA. · Department of Neuropathology, Brain Bank for Aging Research, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan. · Department of Neurology, Saitama Medical University, International Medical Centre, Saitama, Japan. · Department of Anatomy and Neurosciences, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands. · Pubmed 27911006
2016
  • School of Pharmacy, University of Reading, Whiteknights, Reading, RG6 6AP, United Kingdom. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom. · Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, NIA, NIH, Building 35, 35 Convent Drive, Bethesda, MD 20892-3707, USA. · Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, 1 Wakefield Street London WC1N 1PJ, United Kingdom. · Francis Crick Institute, London Research Institute, 44 Lincoln's Inn Fields London, WC2A 3LY, United Kingdom. · Pubmed 27731364
  • Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology; · Pubmed 26780369
2015
  • Department of Biology, University of Padova, Padova, Italy. · San Raffaele Science Park and Università Vita-Salute San Raffaele, Milano, Italy. · Laboratory of Neurogenetics, National Institute on Aging/NIH, Bethesda, Maryland, USA. · Laboratory for Neurobiology and Gene Therapy, KU Leuven, Leuven, Belgium. · Department of Molecular Neuroscience UCL, Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, London, UK. · School of Pharmacy, University of Reading, Reading, UK. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK. · Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Pubmed 26375402
2014
  • Department of Pharmacology and Experimental Therapeutics and Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02215, USA, Howard Hughes Medical Institute, Department of Biomedical Engineering and Center of Synthetic Biology, Boston University, Boston, MA 02215, USA. · Center for Individualized Medicine, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. · Department of Pharmacology and Experimental Therapeutics and. · Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham and Women's Hospital, Cambridge, MA 02139, USA. · Laboratory of Molecular Neurodegenerative Research, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland. · Reta Lila Weston Institute of Neurological Studies, UCL, Institute of Neurology, London, WC1N 1PJ, UK. · Neurodegenerative Studies Laboratory, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. · Department of Neurology and Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. · Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02215, USA, Howard Hughes Medical Institute, Department of Biomedical Engineering and Center of Synthetic Biology, Boston University, Boston, MA 02215, USA, · Department of Pharmacology and Experimental Therapeutics and Department of Neurology, Boston University School of Medicine, Boston, MA, 02118, USA, · Pubmed 24794857
  • Laboratory of Molecular Neurodegenerative Research. · Department of Molecular Neuroscience. · Queen Square Brain Bank for Neurological Disorders, University College London Institute of Neurology, London WC1N 3BG, UK. · Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. · Department of Molecular Neuroscience School of Pharmacy, University of Reading, Reading RG6 6AP, UK. · Reta Lila Weston Institute of Neurological Studies, University College London Institute of Neurology, London WC1N 1PJ, UK. · Neurodegenerative Disease Laboratory, Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. · Laboratory of Molecular Neurodegenerative Research Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA · Pubmed 24740878
  • Reta Lila Weston Laboratories, UCL Institute of Neurology, London, UK. Electronic address: · MRC Protein Phosphorylation Unit. University of Dundee, Dundee, UK. · Reta Lila Weston Laboratories, UCL Institute of Neurology, London, UK. · Reta Lila Weston Laboratories, UCL Institute of Neurology, London, UK; Queen Square Brain Bank, UCL Institute of Neurology, London, UK. · Queen Square Brain Bank, UCL Institute of Neurology, London, UK. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK. · Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK. · Chemical Pathology Department, Great Ormond Street Hospital, London, UK; Clinical and Molecular Genetics Unit, UCL Institute of Child Health, London, UK; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Pubmed 24300239
2010
  • Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London, London, UK. · Pubmed 20036196
2013
  • Reta Lila Weston Institute of Neurological Studies and Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · Pubmed 23664753
  • Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK. Electronic address: · Pubmed 24211199
  • Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, United Kingdom. · Pubmed 23967090
  • Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, UK. · Pubmed 23747310
2011
  • Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom. · Pubmed 21799870
  • Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, UCL, London, UK. · Pubmed 21696411
2010
  • Reta Lila Weston Institute of Neurological Studies, UCL, Institute of Neurology, London, United Kingdom. · Pubmed 20818670
2009
  • Reta Lila Weston Institute of Neurological Disease, Institute of Neurology, University College London, 1, Wakefield Street, WC1N 1PJ, UK. · Pubmed 19716892
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 23 total) written by Rina Bandopadhyay about Parkinson Disease:

  • Parkinson's Disease: Basic Pathomechanisms and a Clinical Overview. 2017
  • SUMOylation and ubiquitination reciprocally regulate α-synuclein degradation and pathological aggregation. 2017
  • LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies. 2017
  • mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1. 2016
  • Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains. 2016
  • Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain. 2015
  • LRRK2 Facilitates tau Phosphorylation through Strong Interaction with tau and cdk5. 2015
  • A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity. 2014
  • Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. 2014
  • Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease. 2014
Show List of Full Article Records
Google Searches

Learn more about Rina Bandopadhyay using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University College London
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University College London
2017
  • Department of Molecular Neuroscience, Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, 1, Wakefield Street, London, WC1N 1PJ, UK. · Department of Molecular Neuroscience, Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, 1, Wakefield Street, London, WC1N 1PJ, UK. · Pubmed 28674978
  • Department of Biochemistry, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel. · Reta Lila Weston Institute of Neurological Studies, University College London Institute of Neurology, London WC1N 1PJ, United Kingdom. · Department of Biochemistry, Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel; · Pubmed 29180403
  • School of Medical Sciences, University of New South Wales, Kensington, Australia. · Neuroscience Research Australia, Randwick, Australia. · Queen Square Brain Bank, UCL Institute of Neurology, University College London, London, UK. · Parkinson's Institute and Clinical Center, Sunnyvale, California, USA. · Department of Neuropathology, Brain Bank for Aging Research, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan. · Department of Neurology, Saitama Medical University, International Medical Centre, Saitama, Japan. · Department of Anatomy and Neurosciences, Neuroscience Campus Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands. · Pubmed 27911006
2016
  • School of Pharmacy, University of Reading, Whiteknights, Reading, RG6 6AP, United Kingdom. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom. · Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, NIA, NIH, Building 35, 35 Convent Drive, Bethesda, MD 20892-3707, USA. · Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, 1 Wakefield Street London WC1N 1PJ, United Kingdom. · Francis Crick Institute, London Research Institute, 44 Lincoln's Inn Fields London, WC2A 3LY, United Kingdom. · Pubmed 27731364
  • Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology; · Pubmed 26780369
2015
  • Department of Biology, University of Padova, Padova, Italy. · San Raffaele Science Park and Università Vita-Salute San Raffaele, Milano, Italy. · Laboratory of Neurogenetics, National Institute on Aging/NIH, Bethesda, Maryland, USA. · Laboratory for Neurobiology and Gene Therapy, KU Leuven, Leuven, Belgium. · Department of Molecular Neuroscience UCL, Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, London, UK. · School of Pharmacy, University of Reading, Reading, UK. · Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK. · Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Pubmed 26375402
2014
  • Department of Pharmacology and Experimental Therapeutics and Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02215, USA, Howard Hughes Medical Institute, Department of Biomedical Engineering and Center of Synthetic Biology, Boston University, Boston, MA 02215, USA. · Center for Individualized Medicine, Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. · Department of Pharmacology and Experimental Therapeutics and. · Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham and Women's Hospital, Cambridge, MA 02139, USA. · Laboratory of Molecular Neurodegenerative Research, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland. · Reta Lila Weston Institute of Neurological Studies, UCL, Institute of Neurology, London, WC1N 1PJ, UK. · Neurodegenerative Studies Laboratory, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. · Department of Neurology and Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. · Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02215, USA, Howard Hughes Medical Institute, Department of Biomedical Engineering and Center of Synthetic Biology, Boston University, Boston, MA 02215, USA, · Department of Pharmacology and Experimental Therapeutics and Department of Neurology, Boston University School of Medicine, Boston, MA, 02118, USA, · Pubmed 24794857
  • Laboratory of Molecular Neurodegenerative Research. · Department of Molecular Neuroscience. · Queen Square Brain Bank for Neurological Disorders, University College London Institute of Neurology, London WC1N 3BG, UK. · Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. · Department of Molecular Neuroscience School of Pharmacy, University of Reading, Reading RG6 6AP, UK. · Reta Lila Weston Institute of Neurological Studies, University College London Institute of Neurology, London WC1N 1PJ, UK. · Neurodegenerative Disease Laboratory, Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. · Laboratory of Molecular Neurodegenerative Research Center for Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA · Pubmed 24740878
  • Reta Lila Weston Laboratories, UCL Institute of Neurology, London, UK. Electronic address: · MRC Protein Phosphorylation Unit. University of Dundee, Dundee, UK. · Reta Lila Weston Laboratories, UCL Institute of Neurology, London, UK. · Reta Lila Weston Laboratories, UCL Institute of Neurology, London, UK; Queen Square Brain Bank, UCL Institute of Neurology, London, UK. · Queen Square Brain Bank, UCL Institute of Neurology, London, UK. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK. · Neurometabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK. · Chemical Pathology Department, Great Ormond Street Hospital, London, UK; Clinical and Molecular Genetics Unit, UCL Institute of Child Health, London, UK; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Pubmed 24300239
2010
  • Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London, London, UK. · Pubmed 20036196
2013
  • Reta Lila Weston Institute of Neurological Studies and Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · Pubmed 23664753
  • Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK. Electronic address: · Pubmed 24211199
  • Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, United Kingdom. · Pubmed 23967090
  • Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, UK. · Pubmed 23747310
2011
  • Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom. · Pubmed 21799870
  • Queen Square Brain Bank, Department of Molecular Neuroscience, UCL Institute of Neurology, UCL, London, UK. · Pubmed 21696411
2010
  • Reta Lila Weston Institute of Neurological Studies, UCL, Institute of Neurology, London, United Kingdom. · Pubmed 20818670
2009
  • Reta Lila Weston Institute of Neurological Disease, Institute of Neurology, University College London, 1, Wakefield Street, WC1N 1PJ, UK. · Pubmed 19716892
Unspecified
2015
  • Neurology Department, Brigham and Women's Hospital, Harvard Medical School , 65 Landsdowne Street, Fourth Floor, Cambridge, Massachusetts 02139, United States. · Department of Genetics and of Biochemistry, Geisel School of Medicine at Dartmouth , One Medical Center Drive HB-7937, Lebanon, New Hampshire 03756, United States. · Reta Lila, Weston Institute of Neurological Studies Department of Molecular Neuroscience UCL, Institute of Neurology 1 , Wakefield Street, London WC1N 1PJ, U.K. · Pubmed 26268594
5 Other Locations Show
Yearly article counts 003224512220
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.